Splenic marginal zone lymphoma differential diagnosis: Difference between revisions

	Splenic marginal zone lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Splenic marginal zone lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Splenic marginal zone lymphoma differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Splenic marginal zone lymphoma differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Splenic marginal zone lymphoma differential diagnosis
CDC on Splenic marginal zone lymphoma differential diagnosis
Splenic marginal zone lymphoma differential diagnosis in the news
Blogs on Splenic marginal zone lymphoma differential diagnosis
Directions to Hospitals Treating Splenic marginal zone lymphoma
Risk calculators and risk factors for Splenic marginal zone lymphoma differential diagnosis

VisualWikitext

Revision as of 18:33, 31 December 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Splenic marginal zone lymphoma must be differentiated from other diseases such as chronic lymphocytic leukemia, follicular lymphoma, and mantle cell lymphoma.^[1]

Differential Diagnosis

Splenic marginal zone lymphoma must be differentiated from other diseases such as:^[1]


Differential Diagnosis	Cytogenetics	Morphology	Immunophenotype

Splenic marginal zone lymphoma	Negative	Negative	Negative
Chronic lymphocytic leukemia	Positive	Negative	Negative
Follicular lymphoma	Negative	Positive	Positive
Splenic Diffuse red Pulp lymphoma	Positive	Negative	Negative
Hairy Celll Leukemia variant	Negative	Positive	Positive
Mantle cell lymphoma	Positive	Negative	Positive
Hairy cell leukeia	Negative	Positive	Positive
Lymphoplasmocytic lymphoma	Positive	Negative	Positive

References

↑ ^1.0 ^1.1 Splenic marginal zone lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd5327/. Accessed on January 14, 2016

Template:WH Template:WS

[cancer.gov-1] 1.0 ^1.1 Splenic marginal zone lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd5327/. Accessed on January 14, 2016

[1]

@@ Line 13: / Line 13: @@
 |+
 ! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}}
-! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD5'''}}
+! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Cytogenetics'''}}
-! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD10'''}}
+! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Morphology'''}}
-! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Cyclin-D1'''}}
+! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Immunophenotype'''}}
 |-
@@ Line 39: / Line 39: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Follicular lymphoma'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Positive'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Positive'''
+|-
+| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
+'''Splenic Diffuse red Pulp lymphoma'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Positive'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
+| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+'''Negative'''
+|-
+| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
+'''Hairy Celll Leukemia variant'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
 '''Negative'''
@@ Line 56: / Line 74: @@
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
-'''Follicular lymphoma'''
+'''Hairy cell leukeia'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
 '''Negative'''
@@ Line 65: / Line 83: @@
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
-'''Mantle cell lymphoma'''
+'''Lymphoplasmocytic lymphoma'''
 | style="padding: 5px 5px; background: #F5F5F5;" align=center|
 '''Positive'''

Splenic marginal zone lymphoma differential diagnosis: Difference between revisions

Revision as of 18:33, 31 December 2018

Overview

Differential Diagnosis

References

Navigation menu